CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
0.8800
-0.0100 (-1.12%)
Jun 5, 2025, 3:45 PM HKT
HKG:0775 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -126.55 | 17.25 | 131.96 | 162.8 | 125.23 | Upgrade
|
Depreciation & Amortization | 245.16 | 233.74 | 230.91 | 246.88 | 220.37 | Upgrade
|
Loss (Gain) From Sale of Assets | -244.83 | -94.63 | -51.51 | 0.76 | 1.8 | Upgrade
|
Asset Writedown & Restructuring Costs | 136.91 | -39.37 | -43.72 | -61.13 | -132.21 | Upgrade
|
Loss (Gain) From Sale of Investments | -5.4 | 0.35 | -0.52 | 1.05 | 3.92 | Upgrade
|
Loss (Gain) on Equity Investments | -0.15 | -0.33 | -0.02 | -1.21 | -1.48 | Upgrade
|
Provision & Write-off of Bad Debts | 5.48 | 0.68 | 20.41 | 2.92 | 14.38 | Upgrade
|
Other Operating Activities | 375.35 | 326.92 | 197.27 | 213.09 | 142.2 | Upgrade
|
Change in Accounts Receivable | -86.9 | 51.43 | -189.54 | -117.36 | 251.17 | Upgrade
|
Change in Inventory | -50.83 | 54.6 | -95.59 | 16.24 | -186.66 | Upgrade
|
Change in Accounts Payable | 105.28 | -36.46 | 164.01 | -40.47 | 92.23 | Upgrade
|
Operating Cash Flow | 353.53 | 514.18 | 363.66 | 423.58 | 530.96 | Upgrade
|
Operating Cash Flow Growth | -31.24% | 41.39% | -14.14% | -20.22% | 40.04% | Upgrade
|
Capital Expenditures | -196.53 | -287.68 | -216.02 | -216.2 | -335.44 | Upgrade
|
Sale of Property, Plant & Equipment | 80.87 | 33.21 | 24.66 | 1.14 | 1.2 | Upgrade
|
Sale (Purchase) of Intangibles | 194.42 | 126.38 | 26.94 | -1.05 | -44.4 | Upgrade
|
Investment in Securities | - | - | -42.9 | - | - | Upgrade
|
Other Investing Activities | 13.95 | 13.19 | 5.72 | 3.01 | 3.17 | Upgrade
|
Investing Cash Flow | -96.65 | -67.96 | -22.12 | -257.88 | -457.31 | Upgrade
|
Long-Term Debt Issued | 1,366 | 3,188 | 1,224 | 1,150 | 4,366 | Upgrade
|
Long-Term Debt Repaid | -1,372 | -3,268 | -1,480 | -1,176 | -3,967 | Upgrade
|
Net Debt Issued (Repaid) | -6.5 | -80.17 | -256.23 | -25.87 | 399.01 | Upgrade
|
Common Dividends Paid | - | -76.89 | -96.11 | -96.11 | -96.11 | Upgrade
|
Other Financing Activities | -335.47 | -320.89 | -163 | -98.1 | -134.15 | Upgrade
|
Financing Cash Flow | -341.98 | -477.95 | -515.34 | -220.08 | 168.74 | Upgrade
|
Foreign Exchange Rate Adjustments | -25.26 | 4.12 | -25.07 | -13.81 | 20.11 | Upgrade
|
Net Cash Flow | -110.35 | -27.61 | -198.87 | -68.2 | 262.49 | Upgrade
|
Free Cash Flow | 157.01 | 226.51 | 147.64 | 207.37 | 195.52 | Upgrade
|
Free Cash Flow Growth | -30.68% | 53.41% | -28.80% | 6.06% | -9.14% | Upgrade
|
Free Cash Flow Margin | 2.84% | 4.25% | 2.80% | 3.84% | 3.96% | Upgrade
|
Free Cash Flow Per Share | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | Upgrade
|
Cash Interest Paid | 335.47 | 320.89 | 163 | 98.1 | 129.37 | Upgrade
|
Cash Income Tax Paid | 17.22 | 66.73 | 48.22 | 18.42 | 52.22 | Upgrade
|
Levered Free Cash Flow | 87.52 | 57.61 | 90.23 | 109.78 | -50.22 | Upgrade
|
Unlevered Free Cash Flow | 298.26 | 259.13 | 192.17 | 170.92 | 30.23 | Upgrade
|
Change in Net Working Capital | -6.8 | -46.78 | -0.38 | 6.6 | -136.73 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.